Ate van der Zee

Prof. Ate van der Zee is a Professor at the University of Groningen, specializing in Gynecologic Oncology. His research focuses on ovarian, vulvar, and cervical cancers, particularly exploring epigenetic mechanisms and clinical applications in cancer therapy. He has contributed to major guidelines such as the European Society of Gynaecological Oncology's vulvar cancer management protocols (2023) and pioneered studies on sentinel node procedures in vulvar cancer.

His work includes establishing patient-derived xenograft models for ovarian cancer and investigating the role of decitabine in epigenetic therapy. He has supervised 43 students and authored over 321 publications. Notable collaborations include the GROINSS-V clinical trials for vulvar cancer treatment. Media engagements include expert commentary on healthcare policy and pediatric heart surgery controversies.

His research integrates molecular biology with clinical oncology, emphasizing translational studies to improve cancer diagnostics and treatment strategies.